MIREIA
COSCOLLA DEVIS
INVEST CONT DOCTOR POSTRYC UV
![Foto de MIREIA](/img/nophoto.png)
![Foto de Instituto de Biomedicina de Valencia](/img/noimage_org.png)
Instituto de Biomedicina de Valencia
Valencia, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Biomedicina de Valencia (9)
2024
-
VIPERA: Viral Intra-Patient Evolution Reporting and Analysis
Virus Evolution, Vol. 10, Núm. 1
2023
-
Genomic analysis of Mycobacterium brumae sustains its nonpathogenic and immunogenic phenotype
Frontiers in Microbiology, Vol. 13
2022
-
Persistent SARS-CoV-2 infection with repeated clinical recurrence in a patient with common variable immunodeficiency
Clinical Microbiology and Infection
-
The structural role of SARS-CoV-2 genetic background in the emergence and success of spike mutations: The case of the spike A222V mutation
PLoS Pathogens, Vol. 18, Núm. 7 July
2021
-
Evolutionary and Phenotypic Characterization of Two Spike Mutations in European Lineage 20E of SARS-CoV-2
mBio, Vol. 12, Núm. 6
-
Local adaptation in populations of Mycobacterium tuberculosis endemic to the Indian Ocean Rim
F1000Research, Vol. 10
-
Spread of a SARS-CoV-2 variant through Europe in the summer of 2020
Nature, Vol. 595, Núm. 7869, pp. 707-712
-
The first wave of the COVID-19 epidemic in Spain was associated with early introductions and fast spread of a dominating genetic variant
Nature Genetics, Vol. 53, Núm. 10, pp. 1405-1414
2016
-
Mycobacterium tuberculosis lineage 4 comprises globally distributed and geographically restricted sublineages
Nature Genetics, Vol. 48, Núm. 12, pp. 1535-1543